Latest News

Market Watch

Senhwa’s Silmitasertib Receives US FDA Fast Track Designation for the Treatment of Recurrent Sonic Hedgehog Driven Medulloblastoma

Aug

18

2021

Yahoo Finance

Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel Oral Drug for COVID-19

Aug

16

2021

PR Newswire

Senhwa Signs Agreement with Taiwan’s CDE for COVID-19 Program Guiding Development of Silmitasertib

Aug

14

2021

Focus Taiwan

CORONAVIRUS/Taiwan COVID-19 drug gets positive review, clinical trials to advance

Mar

15

2021

PR Newswire

Senhwa Announces Acceptance of Early Positive COVID-19 Phase II Study Abstract for Presentation at the ISIRV-WHO Conference

Sep

27

2021

BEING WELL

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Sep

14

2020

Yahoo Finance

Coronavirus Breakthrough: Senhwa Reports First eIND Silmitasertib Treated Severe COVID-19 Patient - Discharged Following Five Days of Treatment

Sep

11

2020

UCSF

Coronavirus forces cells to produce tentacle-like structures that infect neighboring cells

Jul

03

2020